ATE29965T1 - Analgetische und entzuendungshemmende zusammensetzungen mit gehalt an kaffein. - Google Patents

Analgetische und entzuendungshemmende zusammensetzungen mit gehalt an kaffein.

Info

Publication number
ATE29965T1
ATE29965T1 AT83902712T AT83902712T ATE29965T1 AT E29965 T1 ATE29965 T1 AT E29965T1 AT 83902712 T AT83902712 T AT 83902712T AT 83902712 T AT83902712 T AT 83902712T AT E29965 T1 ATE29965 T1 AT E29965T1
Authority
AT
Austria
Prior art keywords
analgesic
compositions containing
containing caffeine
inflammatory compositions
caffeine
Prior art date
Application number
AT83902712T
Other languages
English (en)
Inventor
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Original Assignee
Abraham Sunshine
Eugene M Laska
Carole E Siegel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abraham Sunshine, Eugene M Laska, Carole E Siegel filed Critical Abraham Sunshine
Application granted granted Critical
Publication of ATE29965T1 publication Critical patent/ATE29965T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT83902712T 1982-07-22 1983-07-21 Analgetische und entzuendungshemmende zusammensetzungen mit gehalt an kaffein. ATE29965T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40059782A 1982-07-22 1982-07-22
US06/474,358 US4486436A (en) 1982-07-22 1983-03-11 Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
EP83902712A EP0114886B1 (de) 1982-07-22 1983-07-21 Analgetische und entzündungshemmende zusammensetzungen mit gehalt an kaffein
PCT/US1983/001122 WO1984000490A1 (en) 1982-07-22 1983-07-21 Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same

Publications (1)

Publication Number Publication Date
ATE29965T1 true ATE29965T1 (de) 1987-10-15

Family

ID=27017112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83902712T ATE29965T1 (de) 1982-07-22 1983-07-21 Analgetische und entzuendungshemmende zusammensetzungen mit gehalt an kaffein.

Country Status (8)

Country Link
US (1) US4486436A (de)
EP (2) EP0229022A3 (de)
AT (1) ATE29965T1 (de)
AU (1) AU559218B2 (de)
CA (1) CA1228544A (de)
DE (1) DE3373866D1 (de)
IT (1) IT1206501B (de)
WO (1) WO1984000490A1 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3800301A1 (de) * 1988-01-08 1989-07-20 Rudolf Leitz Procainhaltige salbe und ihre verwendung

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4687781A (en) * 1978-03-03 1987-08-18 Endorfin, Inc. Analgesic and anti-inflammatory compositions
EP0129893B1 (de) * 1983-06-28 1991-09-04 Takeda Chemical Industries, Ltd. Gemahlene Mischung
DE3328401A1 (de) * 1983-08-05 1985-02-21 Merckle GmbH, 7902 Blaubeuren Injizierbare loesung zur behandlung von entzuendungen
US5166141A (en) * 1983-11-01 1992-11-24 Scripps Clinic And Research Foundation Immunostimulating 7-deaza-7-oxa- and 7-deaza-7-oxo-analogs of 8-substituted-guanine-9-(1'-beta-D-aldoglycosidyl) derivatives and methods of treating test animals
JPS60184013A (ja) * 1984-03-01 1985-09-19 Yoshitomi Pharmaceut Ind Ltd 点眼剤
JPS60209515A (ja) * 1984-04-03 1985-10-22 Hokuriku Seiyaku Co Ltd 消炎鎮痛クリ−ム剤
WO1986003681A1 (en) * 1984-12-26 1986-07-03 Abraham Sunshine Analgesic, anti-inflammatory and skeletal muscle relaxant compositions
CH664085A5 (de) * 1985-02-08 1988-02-15 Ciba Geigy Ag Pharmazeutische praeparate mit analgetischer wirksamkeit, sowie deren herstellung.
US4594358A (en) * 1985-02-25 1986-06-10 Eli Lilly And Company Analgesic method
ZA861211B (en) * 1985-02-25 1987-10-28 Lilly Co Eli Analgesic composition
KR890001236B1 (ko) * 1985-10-02 1989-04-28 화이자 인코포레이티드 소염제 조성물의 제조방법
IT1209667B (it) * 1985-11-12 1989-08-30 Zambon Spa Composizione effeverscente adattivita' analgesica.
JPH01501705A (ja) * 1986-01-30 1989-06-15 ユニバ−シテイ・オブ・ユタ 骨損失の治療
CH669523A5 (de) * 1986-06-25 1989-03-31 Mepha Ag
US5286751A (en) * 1987-12-24 1994-02-15 Analgesic Associates Sustained/enhanced antipyretic response
US4927854A (en) * 1987-12-24 1990-05-22 Analgesic Associates Sustained/enhanced analgesia
US5175152A (en) * 1990-09-28 1992-12-29 Singh Nikhilesh N Composition containing ephedrine base and alkyl salicylate for the delivery of ephedrine base in vapor form
US5186222A (en) * 1991-01-07 1993-02-16 Brand Randolf W Fuel spillage control apparatus
JP2829794B2 (ja) * 1991-02-08 1998-12-02 エスエス製薬 株式会社 徐放性経口投与型プラノプロフェン製剤
JPH04346928A (ja) * 1991-05-24 1992-12-02 Doujin Iyaku Kako Kk 坐剤
EP0535937B2 (de) * 1991-10-01 2008-05-21 Takeda Chemical Industries, Ltd. Mikropartikeln-Zusammenfassung zur verlängerten Freigabe und Herstellung derselbe
AU672279B2 (en) * 1992-12-21 1996-09-26 Procter & Gamble Company, The Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
US5760095A (en) * 1995-12-01 1998-06-02 White; Hebron B. Method and system for effecting withdrawal from caffeine dependency
US5648358A (en) * 1996-03-05 1997-07-15 Mitra; Sekhar Compositions and methods for treating respiratory disorders
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
RU2120284C1 (ru) * 1997-07-25 1998-10-20 Генрих Александрович Софронов Комбинированное противовоспалительное, анальгезирующее, жаропонижающее средство
RS49982B (sr) * 1997-09-17 2008-09-29 Euro-Celtique S.A., Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
WO2002022127A1 (en) * 2000-09-13 2002-03-21 Isis Innovation Limited Use of phosphodiesterase inhibitors for the treatment of anorectal disorders
AU2002246397B2 (en) * 2001-04-16 2005-03-24 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8142819B2 (en) 2002-10-21 2012-03-27 Metaproteomics, Llc Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response
US8206753B2 (en) 2001-06-20 2012-06-26 Metaproteomics, Llc Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes
US8168234B2 (en) 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
US7901714B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llp Treatment modalities for autoimmune diseases
US7901713B2 (en) 2001-06-20 2011-03-08 Metaproteomics, Llc Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops
JP2005520778A (ja) 2001-07-06 2005-07-14 エンドー ファーマシューティカルズ， インコーポレイティド 鎮痛薬として使用するための６−ヒドロキシ−オキシモルホンの非経口投与
EP1404332A1 (de) 2001-07-06 2004-04-07 Penwest Pharmaceuticals Company Herstellung von verzögert freisetzenden oxymorphon formulierungen
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
MXPA05004288A (es) 2002-10-21 2005-08-02 Metaproteomics Llc Composiciones para tratar o inhibir los estados patologicos asociados con la respuesta inflamatoria.
WO2004091540A2 (en) * 2003-04-15 2004-10-28 Theraquest Biosciences, Llc Methods of treating pain and compositions for use therefor
RU2237475C1 (ru) * 2003-06-04 2004-10-10 Открытое акционерное общество "Щелковский витаминный завод" Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты)
US20050065172A1 (en) * 2003-09-23 2005-03-24 Shah Indukumar G. Solid dosage form comprising caffeine
US20050067163A1 (en) * 2003-09-25 2005-03-31 George Flint R. Monobore release for tubing conveyed perforating
US7914831B2 (en) 2004-02-27 2011-03-29 Metaproteomics, Llc Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines
US8263139B2 (en) 2005-08-09 2012-09-11 Metaproteonics, Llc Protein kinase modulation by hops and Acacia products
AU2008251756B2 (en) 2007-05-11 2013-06-06 Metaproteomics, Llc Methods and compositions for heavy metal detoxification
US20100190752A1 (en) * 2008-09-05 2010-07-29 Gruenenthal Gmbh Pharmaceutical Combination
US20110064813A1 (en) * 2009-09-16 2011-03-17 Charles Vaughn Use of salsalate with or without caffeine and with or without omega 3, and other pharmaceutical compounds in a distinctively unique nano-particulate capsule and tablet
US12053464B2 (en) * 2017-10-20 2024-08-06 Purdue Pharma L.P. Pharmaceutical dosage forms
US12194046B2 (en) 2021-03-09 2025-01-14 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3439094A (en) * 1967-07-20 1969-04-15 Warner Lambert Pharmaceutical Analgesic compositions containing namol xenyrate,caffeine and acetyl-rho-aminophenol
US4404210A (en) * 1982-06-30 1983-09-13 E. I. Du Pont De Nemours And Company Analgesic mixture of nalbuphine and ibuprofen

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3800301A1 (de) * 1988-01-08 1989-07-20 Rudolf Leitz Procainhaltige salbe und ihre verwendung

Also Published As

Publication number Publication date
EP0114886B1 (de) 1987-09-30
EP0229022A3 (de) 1989-11-08
AU559218B2 (en) 1987-02-26
CA1228544A (en) 1987-10-27
US4486436A (en) 1984-12-04
DE3373866D1 (en) 1987-11-05
EP0229022A2 (de) 1987-07-15
WO1984000490A1 (en) 1984-02-16
IT1206501B (it) 1989-04-27
EP0114886A1 (de) 1984-08-08
IT8322171A0 (it) 1983-07-21
AU1887783A (en) 1984-02-23

Similar Documents

Publication Publication Date Title
ATE29965T1 (de) Analgetische und entzuendungshemmende zusammensetzungen mit gehalt an kaffein.
SE8503762D0 (sv) Analgetiska och anti-inflammatoriska kompositioner innefattande xantiner och forfarande for anvendning av dessa
DE68901417D1 (de) Pharmazeutische zusammensetzung.
DK372786A (da) Farmaceutiske praeparater af phenindamin (2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridin)
DE3586545D1 (de) Erhoehte schmerzlosigkeit bewirkende pharmazeutische zusammensetzungen.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
IT8323205A0 (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
IT1209667B (it) Composizione effeverscente adattivita' analgesica.
ATE22007T1 (de) Pharmazeutische mischung.
DE3863963D1 (de) Pharmazeutische zusammensetzungen.
IT8821134A0 (it) Frazioni oligomeriche procianidoliche, loro procedimentodi preparazione e composizioni farmaceutiche che le contengono.
GB2134786A (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
SE8401537D0 (sv) Forbettrade analgetiska och anti-inflammatoriska kompositioner innefattande ibuprofen och sett att anvenda dessa
FI893643A0 (fi) Farmaceutiska kompositioner.
DE3682083D1 (de) Pharmazeutische zusammensetzungen.
DE3784595D1 (de) Arzneimittel gegen feste tumoren.
DE3674040D1 (de) Pharmazeutische zusammensetzungen.
IT8123488A0 (it) Metaboliti, loro preparazione eloro impiego in terapeutica.
DE3866789D1 (de) Pharmazeutische zusammensetzungen.
IT8219804A0 (it) Formulazioni farmaceutiche adattivita' antiinfiammatoria, analgesica, antipiretica e gastroprotettiva.
ATE78161T1 (de) 4-aroylimidazol-2-on enthaltende pharmazeutische zusammensetzung.
IT8320808A0 (it) Preparati farmaceutici ad azione analgesica conteneti 5 fenil-1,4-benzodiazepine.
ES1011580Y (es) Dispositivo nebulizador para esmaltes y similares.
ATE34918T1 (de) Pharmazeutische gelzusammensetzung.
ES265931Y (es) "dispositivo para la presentacion, en bateria, de dosis de microcomprimidos medicamentosos".

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee